Pyrazolopyrazine compounds as SHP2 inhibitors

By developing SHP2 inhibitors with specific chemical structures, the problem of difficulty in inhibiting SHP2 in the prior art is solved, and effective treatment of brain cancer is achieved, and broad therapeutic potential is available.

CN119212994APending Publication Date: 2024-12-27GENZYME CORP +1
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202280089698.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Priority Date
2022-12-08
Filing Date
2022-12-16
Publication Date
2024-12-27

Smart Images

  • Figure BDA0004955966100000021
    Figure BDA0004955966100000021
  • Figure BDA0004955966100000042
    Figure BDA0004955966100000042
  • Figure BDA0004955966100000061
    Figure BDA0004955966100000061
Patent Text Reader

Abstract

Provided herein are compounds and pharmaceutical compositions thereof for modulating SHP2 and their use in the treatment of disease.
Need to check novelty before this filing date? Find Prior Art